COVID-19 impact on ST-elevation myocardial infarction incidence rate in a Italian STEMI network: a U-shaped curve phenomenon.


Journal

Journal of cardiovascular medicine (Hagerstown, Md.)
ISSN: 1558-2035
Titre abrégé: J Cardiovasc Med (Hagerstown)
Pays: United States
ID NLM: 101259752

Informations de publication

Date de publication:
01 05 2021
Historique:
pubmed: 6 1 2021
medline: 20 4 2021
entrez: 5 1 2021
Statut: ppublish

Résumé

Public health emergencies such as the COVID-19 outbreak may impact on the incidence rate of ST-elevation myocardial infarction (STEMI) in severely affected areas. However, this phenomenon demands attention also in areas where media and patients were focused on the COVID-19 pandemic, but the healthcare system was not overwhelmed by the huge number of COVID-19 patients. In this observational study, we compared the incidence rate of all consecutive STEMI patients admitted at the University Hospital of Trieste, Italy, during March and April 2020 with the same 2 months of the previous 5 years (2015-2019). Patient characteristics were compared between 2020 and 2019.The incidence rate of STEMI admission in March-April 2020 was lower than those in March-April 2015-2019, 36 vs. 56 cases per 100 000 inhabitants/year [relative risk (RR) 0.65, 95% confidence interval (95% CI) 0.42-0.96, P = 0.045]. Considering that the incidence rates were constant in the past years (P = 0.24), the turnaround in 2020 is most likely due to the COVID-19 outbreak. Interestingly, this reduction was a dynamic phenomenon with a U-shaped curve during the 2-month period. System-of-care times were similar between 2020 and 2019; however in 2020, patients presented more frequently signs of heart failure compared to 2019 (Killip class ≥2 in 68% vs. 29%, P = 0.003). During the COVID-19 outbreak, we observed a marked reduction in the STEMI incidence rate. This U-shaped phenomenon demands attention because a potential cause for the decrease in STEMI incidence may include the avoidance of medical care. Public campaigns aiming to increase awareness of ischemic symptoms may be needed during community outbreak.

Sections du résumé

BACKGROUND
Public health emergencies such as the COVID-19 outbreak may impact on the incidence rate of ST-elevation myocardial infarction (STEMI) in severely affected areas. However, this phenomenon demands attention also in areas where media and patients were focused on the COVID-19 pandemic, but the healthcare system was not overwhelmed by the huge number of COVID-19 patients.
METHODS AND RESULTS
In this observational study, we compared the incidence rate of all consecutive STEMI patients admitted at the University Hospital of Trieste, Italy, during March and April 2020 with the same 2 months of the previous 5 years (2015-2019). Patient characteristics were compared between 2020 and 2019.The incidence rate of STEMI admission in March-April 2020 was lower than those in March-April 2015-2019, 36 vs. 56 cases per 100 000 inhabitants/year [relative risk (RR) 0.65, 95% confidence interval (95% CI) 0.42-0.96, P = 0.045]. Considering that the incidence rates were constant in the past years (P = 0.24), the turnaround in 2020 is most likely due to the COVID-19 outbreak. Interestingly, this reduction was a dynamic phenomenon with a U-shaped curve during the 2-month period. System-of-care times were similar between 2020 and 2019; however in 2020, patients presented more frequently signs of heart failure compared to 2019 (Killip class ≥2 in 68% vs. 29%, P = 0.003).
CONCLUSION
During the COVID-19 outbreak, we observed a marked reduction in the STEMI incidence rate. This U-shaped phenomenon demands attention because a potential cause for the decrease in STEMI incidence may include the avoidance of medical care. Public campaigns aiming to increase awareness of ischemic symptoms may be needed during community outbreak.

Identifiants

pubmed: 33399345
doi: 10.2459/JCM.0000000000001153
pii: 01244665-202105000-00003
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

344-349

Informations de copyright

Copyright © 2021 Italian Federation of Cardiology - I.F.C. All rights reserved.

Références

Romeo F, Calcaterra G, Barilla F, Mehta JL. Coronavirus disease 2019 infection and the cardiovascular system. J Cardiovasc Med (Hagerstown) 2020; 21:403–405.
Coronavirus Disease 2019 (COVID-19) Situation Report-101. https://www.Who.Int/Docs/Default-Source/Coronaviruse/Situation-Reports/20200430-Sitrep-101-Covid-19.Pdf?Sfvrsn=2ba4e093_2 ).
The Mystery of the Missing STEMIs During the COVID-19 Pandemic | tctmd.com. https://www.tctmd.com/news/mystery-missing-stemis-during-covid-19-pandemic .
COVID-19/dati-regioni. https://github.com/pcm-dpc/COVID-19/blob/master/dati-regioni/dpc-covid19-ita-regioni-20200430.csv .
Ibanez B, James S, Agewall S, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 2018; 39:119–177.
Garcia S, Albaghdadi MS, Meraj PM, et al. Reduction in ST-segment elevation cardiac catheterization laboratory activations in the United States during COVID-19 pandemic. J Am Coll Cardiol 2020; 75:2871–2872.
Romaguera R, Cruz-González I, Jurado-Román A, et al. Considerations on the invasive management of ischemic and structural heart disease during the COVID-19 coronavirus outbreak. REC Interv Cardiol 2020; 2:112–117.
De Rosa S, Spaccarotella C, Basso C, et al. Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era. Eur Heart J 2020; 41:2083–2088.
Danzi GB, Olivotti L, Valenti R, et al. Trends of percutaneous coronary intervention in Italy in the last 10 years. J Cardiovasc Med (Hagerstown) 2017; 18:170–177.
Fabris E, Van’t Hof A, Hamm CW, et al. Impact of presentation and transfer delays on complete ST-segment resolution before primary percutaneous coronary intervention: insights from the ATLANTIC trial. EuroIntervention 2017; 13:69–77.
Cerrato E, Forno D, Ferro S, Chinaglia A. Characteristics, in-hospital management and outcome of late acute ST-elevation myocardial infarction presenters. J Cardiovasc Med (Hagerstown) 2017; 18:567–571.
Fabris E, Arrigoni P, Falco L, et al. Impact of patient delay in a modern real world STEMI network. Am J Emerg Med 2020; 0:1195–1198.
Fabris E, van ’t Hof A, Hamm CW, et al. Clinical impact and predictors of complete ST segment resolution after primary percutaneous coronary intervention: a subanalysis of the ATLANTIC Trial. Eur Hear J Acute Cardiovasc Care 2017; 8:208–217.
Gatto L, Romagnoli E, Versaci F, et al. The role of residual intrastent thrombus during primary angioplasty: insights from the COCTAIL II study. J Cardiovasc Med (Hagerstown) 2017; 18:348–353.
Baldi C, Polito MV, Citro R, et al. Prognostic value of clinical, echocardiographic and angiographic indicators in patients with large anterior ST-segment elevation myocardial infarction as a first acute coronary event. J Cardiovasc Med 2017; 18:946–953.
De Luca G, Verdoia M, Savonitto S, et al. Impact of diabetes on clinical outcome among elderly patients with acute coronary syndrome treated with percutaneous coronary intervention: insights from the ELDERLY ACS 2 trial. J Cardiovasc Med (Hagerstown) 2020; 21:453–459.
Paoli A, Brischigliaro L, Scquizzato T, Favaretto A, Spagna A. Out-of-hospital cardiac arrest during the COVID-19 pandemic in the Province of Padua, Northeast Italy. Resuscitation 2020; 154:47–49.
Sayre MR, Barnard LM, Counts CR, et al. Prevalence of COVID-19 in out-of-hospital cardiac arrest: implications for bystander CPR. Circulation 2020; 142:507–509.
Marijon E, Karam N, Jost D, et al. Out-of-hospital cardiac arrest during the COVID-19 pandemic in Paris, France: a population-based, observational study. Lancet Public Heal 2020; 5:e437–e443.
Baldi E, Sechi GM, Mare C, et al. Out-of-hospital cardiac arrest during the Covid-19 outbreak in Italy. N Engl J Med 2020; 383:496–498.

Auteurs

Enrico Fabris (E)

Cardiovascular Department.

Riccardo Bessi (R)

Cardiovascular Department.

Annamaria De Bellis (A)

Cardiovascular Department.

Caterina Gregorio (C)

Biostatistics Unit, Department of Medical Sciences.

Alberto Peratoner (A)

Emergency Department, University of Trieste, Trieste.

Gerardina Lardieri (G)

Division of Cardiology, Gorizia - Monfalcone Hospital, ASUGI, Gorizia, Italy.

Franco Cominotto (F)

Emergency Department, University of Trieste, Trieste.

Giancarlo Vitrella (G)

Cardiovascular Department.

Serana Rakar (S)

Cardiovascular Department.

Andrea Perkan (A)

Cardiovascular Department.

Gianfranco Sinagra (G)

Cardiovascular Department.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH